Dyslipidemias - Clinical Features and Management Flashcards

1
Q

Lipid hypothesis:

A

-elevated serum cholesterom levels directly linked to atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Major modifiable risk factors for atherosclerosis:

A
  • smoking
  • diabetes mellitus
  • HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

intensity of ASCVD-preventative therapy is based on:

A

-serum lipid levels AND risk factors!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non drug treatment:

A
  • diet mod
  • regular exercise
  • attain and maintain optimum weight
  • not smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

High Total cholesterol level

A

260<

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hgih LDL-C level?

A

160<

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which diet works well for high LDL-C diet?

A

DASH DIET (dietary approach to stop hypertension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the target level for LDL-C treatment?

A

there is no level anymore - we match the intensity of preventative treatment to absolute individual risk of ASCVD over 10 year period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug of choice for cholesterol dyslipidemias?

A

-STATINS - HMG-CoA reductase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benefit to using statis?

A
  • reduce LDL and TG
  • increase HDL
==> reduce major coronary events
==>reduce CAD mortality
==>reduce coronary procedures
==> reduce stroke
==> reduce total mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Major side effects to statins:

A
  • myopathy

- inc liver enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindication to statins?

A

-liver disease!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

4 major statin benefit groups:

A

1) secondary prevention - clinical ASCVD
2) Primary prevention-individuals with pimary LDL elevation >190
3) Primary prevention-diabetics 40-75yo and LDL level 70-189
4) primary prevention-without diabetes but estimated 10-year CVD risk>=7.5%, age 40-75 with LDL 70-189

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What to give patients with ASCVD (CHD, nonfatal MI< stroke..etc) and=7.5%?

A

HIGH INTENSITY STATIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Do not use statin therapy for people with:

A

heart failure class 2-4 and people on maintenance hemodialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

If 21yr or older patient with just LDL>=190 but no clinical ASCVD - what to do?

A

just need to start on hgih intensity statin

17
Q

If 21yo without diabetes and LDL-C 70-189 with estimated 10yr risk of 7.5% of greater-what to do?

A

-mod or high intensity statin

18
Q

Less than 75 with no safety concerns but has clinical ASCVD - what to do?

A

high intensity statin (secondary prevention)

19
Q

Older than 75 with safety concerns and clinical ASCVD - what to do?

A

moderate intensity statin (secondary prevention)

20
Q

LDL-C>=190 but no clinical ASCVD - what to do?

A

(primary prevention)

  • look for secondary causes of dyslipidemias
  • high intensity statin
  • try to reduce LDL-C by more than 50%
  • LDL-C non statin therapy
21
Q

high intensity statins:

A

Atorvastatin

rosuvastatin

22
Q

Moderate intensity statins:

A
atorvastatin
rosuvastatin
simvastatin
pravastatin
lovastatin
23
Q

Low intensity statins:

A

pravastatin

lovastatin

24
Q

Bile acid sequestrants

  • major actions
  • side effects
A

1) reduce LDL 15-30%
- raise HDL 3-5%
- may inc TG
2) -GI issues
- dec absorption of other drugs

25
Bile acid sequestrants | -contrainications:
- hgih TGs | - dysbetalipoproteinemia
26
Bile acid sequestrant drugs:
- cholestyramine - cholestipol - colesevelam
27
Bile acid sequestrants - benefits:
- reduce major coronary events | - reduce CAD mortality
28
nicotinic acid - major actions - side effects:
1) lowers LDL 5-25% -lowers TG20-50% -raises HDL 15-35% 2) flushing hyperglycemia hyperuricemia upper GI distress liver tox
29
(NIACIN) nicotinic acid -contraindications:
- liver disease - severe gout - peptic ulcer
30
nicotinic acid - benefits:
- reduces major coronary events | - possible reduction in total mortality
31
fibric acid derivatives: - used for? - actions?
- mostly used for hyperTGs - lower LDL 5-20% (if nml TG) - may raise LDL (if high TG) - lower TG 20-50% - raise HDL 10-20%
32
Fibric acids - side effects: - contraindications:
1) dyspepsia gallstones myopathy 2) Severe renal or hepatic disease
33
fibric acids therapeutic bebefits:
- reduce progression of coronary lesions | - reduce major coronary events